AngioDynamics, Inc.
Rank #39StartupANGO · Nasdaq · Healthcare
AngioDynamics, Inc. (ANGO) — Rank #39 by gross profitability (GP/assets 0.65) · ROE -21.5% · Piotroski F-Score N/A.
As-of 2026-09-28 · CIK 0001275187 · all metrics point-in-time as of the filing date.
About
AngioDynamics, Inc., a medical technology company, designs, manufactures, and sells products for the treatment of cardiovascular disease and cancer diagnoses in the United States and internationally.
Show moreShow less
The company operates through Med Tech and Med Device segments. It offers Auryon Atherectomy system that delivers an optimized wavelength and short pulse width to remove lesions while preserving vessel wall endothelium. The company's thrombus management portfolio includes AlphaVac mechanical thrombectomy system, an emergent mechanical aspiration device that eliminates the need for perfusionist support; thrombolytic catheters that are used to deliver thrombolytic agents, which are drugs to dissolve blood clots in hemodialysis access grafts, arteries, veins, and surgical bypass grafts; and AngioVac venous drainage cannula and extracorporeal circuit for use in extracorporeal circulatory support procedures for periods of up to six hours, as well as with other manufacturers' off-the-shelf pump, filter, and reinfusion cannula facilitate venous drainage. It also offers NanoKnife IRE Ablation System, an alternative to traditional thermal ablation for the surgical ablation of soft tissue; and peripheral products, which include angiographic catheters, guidewires, drainage catheters, and micropuncture kits for use in invasive procedures. In addition, the company provides total abscession drainage catheters for multi-purpose/general and biliary configurations, and nephrostomy options; mini stick MAX Coaxial microintroducer kits and micro-introducer kits; ports; VenaCure EVLT system that are used in endovascular laser procedures to treat superficial venous disease; and Solero Microwave Tissue Ablation System includes solero microwave generator and the solero MW applicators. AngioDynamics, Inc.
was founded in 1988 and is headquartered in Latham, New York.
- Industry
- Medical Instruments & Supplies
- Sector
- Healthcare
- State
- DE
- Filer Category
- Accelerated filer
- Fiscal Year End
- May 31
- Website
- angiodynamics.com
Financials
Each fiscal year is read as-of that year’s own 10-K filing, so nothing restated after the fact leaks backwards. Line items this filer never tagged are omitted. Hover or tap a badge for the diagnostic behind it.
| Fiscal year end | 2026-05-31filed 2026-07-14 | 2025-05-31filed 2025-07-18 | 2024-05-31filed 2024-07-25 | 2023-05-31filed 2023-08-03 |
|---|---|---|---|---|
| Operating | ||||
| Depreciation & amortization | 23.0 | 25.8 | 27.7 | 30.9 |
| Stock-based compensation | 14.0 | 9.8 | 10.5 | 11.2 |
| Change in receivables | 5.8 | (0.0) | (7.9) | 1.3 |
| Change in inventory | (10.0) | 1.3 | 9.4 | 8.2 |
| Operating cash flow | 3.1 | (10.1) | (28.2) | 0.1 |
| Investing | ||||
| Capital expenditures | 2.6 | 4.5 | 2.5 | 3.8 |
| Investing cash flow | (5.9) | (10.2) | 123.7 | (9.7) |
| Financing | ||||
| Debt issued | — | — | — | — |
| Debt repaid | 0.0 | 0.0 | 50.0 | 45.0 |
| Share repurchases | 0.0 | 1.7 | — | — |
| Financing cash flow | 0.6 | (0.3) | (64.2) | 25.4 |
| Summary | ||||
| Free cash flow | 0.5 | (14.6) | (30.7) | (3.7) |
Figures are as originally filed with the SEC (point-in-time), not restated, so they can differ slightly from sites that show later-restated numbers. Why point-in-time?